Compass Therapeutics, Inc.CMPXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+23.1%
5Y CAGR+30.3%
Year-over-Year Change
Research and development spending
3Y CAGR
+23.1%/yr
vs +2.6%/yr prior
5Y CAGR
+30.3%/yr
Recent deceleration
Acceleration
+20.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $55.97M | +32.2% |
| 2024 | $42.34M | +11.1% |
| 2023 | $38.12M | +27.1% |
| 2022 | $30.00M | +47.5% |
| 2021 | $20.34M | +36.5% |
| 2020 | $14.90M | -33.6% |
| 2019 | $22.45M | -17.1% |
| 2018 | $27.09M | - |